Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Two vs Three Cycles Induction Chemotherapy in Locally Advanced Nasopharyngeal Carcinoma
NCT05860868Phase 3Recruiting
- Sponsor
- The First Affiliated Hospital of Sun Yat-sen University
- Start
- May 2023
- Primary completion
- May 2028
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Cisplatin micelle injection (HA132), docetaxel, fluorouracil, gemcitabine in nasopharyngeal carcinoma (NPC), sponsored by The First Affiliated Hospital of Sun Yat-sen University. Started May 2023; status: recruiting.
02
Drugs
Cisplatin micelle injection (HA132)docetaxelfluorouracilgemcitabine
03
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on NCT05860868.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05860868.